A Study of LY3471851 in Participants With Eczema

Condition:   Dermatitis, Atopic Interventions:   Drug: LY3471851;   Drug: Placebo Sponsors:   Eli Lilly and Company;   Nektar Therapeutics Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials